28.31

1.91% -0.55

After Hours: 28.13 -0.18 -0.64%

Capricor Therapeutics Inc (CAPR)

Overview News Price History Option Chain Financials Why CAPR Down? Discussions Forecast Stock Split

Capricor Therapeutics Inc stock is traded at $28.31, with a volume of 1.33M. It is down -1.91% in the last 24 hours and up +345.13% over the past month. Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Previous Close:

$28.86

Open:

$29.09

24h Volume:

1.33M

Relative Volume:

0.50

Market Cap:

$1.54B

Revenue:

$27.10M

Net Income/Loss:

$-24.31M

P/E Ratio:

-34.11

EPS:

-0.83

Net Cash Flow:

$-33.33M

1W Performance:

-4.65%

1M Performance:

+345.13%

6M Performance:

+182.53%

1Y Performance:

+89.24%

1-Day Range:

$27.51

$29.36

1-Week Range:

$27.51

$30.71

52-Week Range:

$4.30

$40.37

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Name

Capricor Therapeutics Inc

Sector

Healthcare (1131)

Industry

Biotechnology (631)

Phone

(310) 358-3200

Address

10865 ROAD TO THE CURE, SAN DIEGO, CA

Employee

160

Twitter

@Capricor

Next Earnings Date

2025-03-19

Latest SEC Filings

CAPR's Discussions on Twitter

Compare CAPR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CAPR Capricor Therapeutics Inc	28.31	1.57B	27.10M	-24.31M	-33.33M	-0.83
VRTX Vertex Pharmaceuticals Inc	452.13	115.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.31	81.12B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.17	52.54B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	839.99	51.78B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.12	37.12B	447.02M	-1.18B	-906.14M	-6.1812

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-25	Initiated	Alliance Global Partners	Buy
Jun-26-25	Initiated	B. Riley Securities	Buy
May-20-25	Initiated	Roth Capital	Buy
Oct-21-24	Initiated	Piper Sandler	Overweight
May-17-24	Initiated	Oppenheimer	Outperform
Jan-05-24	Initiated	Cantor Fitzgerald	Overweight
Oct-26-22	Initiated	Ladenburg Thalmann	Buy
Dec-26-18	Downgrade	Maxim Group	Buy → Hold
Jan-26-18	Reiterated	H.C. Wainwright	Buy
Sep-15-17	Reiterated	H.C. Wainwright	Buy
Feb-13-17	Resumed	Rodman & Renshaw	Buy
Jul-06-16	Resumed	H.C. Wainwright	Buy
Jun-15-16	Initiated	ROTH Capital	Buy

View All

Capricor Therapeutics Inc Stock (CAPR) Latest News

Dec 30, 2025

‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win - MSN

Dec 30, 2025

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 4.5%Here's What Happened - MarketBeat

Dec 30, 2025

Best Biotech Stocks To ConsiderDecember 7th - MarketBeat

Dec 30, 2025

HBK Sorce Advisory LLC Buys 42,951 Shares of Capricor Therapeutics, Inc. $CAPR - MarketBeat

Dec 30, 2025

Dec 27, 2025

Analyst Downgrade: How interest rate cuts could boost Capricor Therapeutics Inc stockWeekly Stock Analysis & Daily Profit Focused Stock Screening - moha.gov.vn

Dec 27, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Dec 27, 2025

Dec 26, 2025

(CAPR) Volatility Zones as Tactical Triggers - Stock Traders Daily

Dec 26, 2025

Dec 25, 2025

Trend Review: Why Capricor Therapeutics Inc. stock attracts high net worth investors2025 Buyback Activity & Safe Investment Capital Preservation Plans - moha.gov.vn

Dec 25, 2025

HBK Sorce Advisory LLC Raises Stake in Capricor Therapeutics, Inc. $CAPR - MarketBeat

Dec 25, 2025

Short Interest in Capricor Therapeutics, Inc. (NASDAQ:CAPR) Decreases By 69.4% - MarketBeat

Dec 25, 2025

Dec 23, 2025

Capricor Therapeutics (CAPR) price target increased by 32.98% to 51.82 - MSN

Dec 23, 2025

Dec 22, 2025

Top Medical Stocks To ResearchDecember 3rd - MarketBeat

Dec 22, 2025

Assessing Capricor Therapeutics (CAPR) Valuation After Positive HOPE-3 Data and Nippon Shinyaku Commercialization Deal - Sahm

Dec 22, 2025

Dec 21, 2025

Capricor Therapeutics launches proposed public offering of common stock - MSN

Dec 21, 2025

Dec 20, 2025

Earnings Risk: Is ARK Autonomous Technology & Robotics stock cheap by valuation metricsMarket Trend Summary & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn

Dec 20, 2025

Why Capricor Therapeutics Inc. stock attracts high net worth investors2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда

Dec 20, 2025

How Capricor Therapeutics Inc. (4LN2) stock trades pre earningsQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru

Dec 20, 2025

Does Capricor Therapeutics Inc. stock trade at a discount to peers2025 Analyst Calls & Advanced Technical Signal Analysis - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.8%What's Next? - MarketBeat

Dec 19, 2025

Capricor Therapeutics (STU:4LN2) EV-to-OCF : -21.03 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Capricor Therapeutics (STU:4LN2) EV-to-FCF : -18.80 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Can Capricor Therapeutics Inc. stock reach $100 price target2025 Pullback Review & Weekly Sector Rotation Insights - ulpravda.ru

Dec 19, 2025

Why Capricor Therapeutics Inc. (4LN2) stock is a strong analyst pick2025 Bull vs Bear & Low Drawdown Investment Ideas - DonanımHaber

Dec 19, 2025

CAPR stock price: Why is Capricor Therapeutics stock surging over 293% today? - MSN

Dec 19, 2025

Can Capricor Therapeutics Inc. (4LN2) stock double in coming years2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

How Capricor Therapeutics Inc. stock reacts to global recession fears2025 Risk Factors & Weekly Stock Breakout Alerts - Улправда

Dec 18, 2025

How Capricor Therapeutics Inc. (4LN2) stock benefits from digital adoptionRecession Risk & Target Return Focused Stock Picks - Улправда

Dec 18, 2025